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Abstract. 
 
Paxillin is a focal adhesion adapter protein
involved in the integration of growth factor– and adhe-
sion-mediated signal transduction pathways. Paxillin
LD motifs have been demonstrated to bind to several
proteins associated with remodeling of the actin cyto-
skeleton including the focal adhesion kinase, vinculin,
 
and a complex of proteins comprising p95PKL, PIX,
and  PAK (Turner, C.E., M.C. Brown, J.A. Perrotta, M.C.
Riedy, S.N. Nikolopoulos, A.R. McDonald, S. Bagrodia, S.
 
Thomas, and P.S. Leventhal. 1999. 
 
J. Cell Biol
 
. 145:851–
863). In this study, we report the cloning and initial
characterization of a new paxillin LD motif–binding
protein, actopaxin. Analysis of the deduced amino acid
sequence of actopaxin reveals a 42-kD protein with two
calponin homology domains and a paxillin-binding sub-
domain (PBS). Western blotting identiﬁes actopaxin as
a widely expressed protein. Actopaxin binds directly to
both F-actin and paxillin LD1 and LD4 motifs. It exhib-
its robust focal adhesion localization in several cultured
 
cell types but is not found along the length of the asso-
ciated actin-rich stress ﬁbers. Similar to paxillin, it is
absent from actin-rich cell–cell adherens junctions.
Also, actopaxin colocalizes with paxillin to rudimentary
focal complexes at the leading edge of migrating cells.
An actopaxin PBS mutant incapable of binding paxillin
in vitro cannot target to focal adhesions when ex-
pressed in ﬁbroblasts. In addition, ectopic expression of
the PBS mutant and/or the COOH terminus of acto-
paxin in HeLa cells resulted in substantial reduction in
 
adhesion to collagen. Together, these results suggest an
 
important role for actopaxin in integrin-dependent re-
modeling of the actin cytoskeleton during cell motility
and cell adhesion.
Key words: actin-binding protein • CH domains • fo-
cal adhesions • paxillin • hic-5
 
Introduction
 
Cell adhesion and migration are integral components of
many biological processes including normal development
and recovery from injury and infection. These processes
are regulated in part by signals received by cells through
the engagement of integrins with the extracellular matrix
in combination with exposure to soluble growth factors
(Clark and Brugge, 1995; Craig and Johnson, 1996). The
integrin–extracellular matrix interaction catalyzes the re-
cruitment of multiple cytoskeletal-associated proteins to
the cytoplasmic face of structures called focal adhesions,
triggering a physical linkage between the extracellular
matrix and the actin-based cytoskeleton (Turner and
 
Burridge, 1991; Jockusch et al., 1995). Some focal adhe-
sion proteins such as vinculin, talin, and 
 
a
 
-actinin function
 
solely to provide a structural link between integrins and
F-actin, whereas others such as the focal adhesion kinase
 
(FAK),
 
1
 
 Cas, and paxillin function as scaffold proteins
and are involved in coordinating integrin-mediated signal
 
transduction (Burridge and Chrzanowska-Wodnicka, 1996)
associated with the regulation of cell motility, gene expres-
sion, and cell proliferation (Giancotti and Ruoslahti,
1999).
Paxillin is a multidomain adapter protein composed of
protein–protein interaction motifs (Turner et al., 1990;
Turner, 1998). The COOH terminus of paxillin is com-
prised of four LIM domains that mediate paxillin targeting
to focal adhesions (Brown et al., 1996, 1998b) as well as
binding to the tyrosine phosphatase PTP-PEST (Shen et
 
al., 1998; Coté et al., 1999). The NH
 
2
 
 terminus of paxillin
supports the binding of vinculin and several protein ty-
rosine kinases including FAK, PYK2, Csk, and Src (Sabe
et al., 1994; Turner and Miller, 1994; Schaller and Parsons,
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1995; Tachibana et al., 1995; Salgia et al., 1996). Paxillin
also binds to 
 
a
 
4 integrins (Liu et al., 1999).
We have identified five leucine-rich sequences (LDX-
LLXXL) within the NH
 
2
 
 terminus of paxillin named LD
motifs that are highly conserved between species and be-
tween other paxillin family members such as hic-5 and
 
Dictyostelium discoideum
 
 PaxB (Brown et al., 1996,
1998a). The paxillin LD motifs serve as binding sites for
both FAK and vinculin (Brown et al., 1996; Turner, 1998;
Turner et al., 1999), and the E6 oncoprotein from papillo-
mavirus (Tong et al., 1997; Vande Pol et al., 1998). Re-
cently, we described a novel scaffolding function for the
paxillin LD4 motif in the binding of a complex of proteins
containing the ADP-ribosylation factor (Arf) GTPase–
activating protein, paxillin-kinase linker (p95PKL), the
p21-Cdc42/Rac GTPase–activated serine threonine kinase
(PAK), Nck, and the guanine nucleotide exchange factor
PIX/COOL (Turner et al., 1999). The p21 GTPases of the
Rho family (Cdc42, Rac, and Rho) and their effectors such
as PAK and ROK play a pivotal role in regulating remod-
eling of the actin cytoskeleton and change in gene expres-
sion in response to stimulation of quiescent cells with
growth factors or after cell adhesion (Clark et al., 1998;
Hall, 1998; Price et al., 1998; Bagrodia and Cerione, 1999;
Daniels and Bokoch, 1999). More recently, the Arf family
of small GTPases have also been implicated in remodeling
of the actin cytoskeleton (Van Aelst and D’Souza-Scho-
rey, 1997; Frank et al., 1998; Song et al., 1998) in addition
to their role in vesicle transport (Donaldson and Klausner,
1994; Radhakrishna and Donaldson, 1997). Additional
members of the Arf GAP family that also bind to paxillin
have been reported recently including P95-APP1 (Di Ce-
sare et al., 2000), GIT-1 (Premont et al., 2000), and PAG3
(Kondo et al., 2000). Thus, paxillin, through its multiple
protein–protein interactions, likely serves as an important
mediator of cytoskeletal reorganization and as a potential
site of integration of Rho GTPase and Arf GTPase signal-
ing (Norman et al., 1998; Turner et al., 1999).
Here we report the identification and characterization of
another paxillin LD motif–binding protein, p42 actopaxin.
We demonstrate that actopaxin, a tandem calponin homol-
ogy (CH) domain–containing protein, binds directly to
paxillin and F-actin and colocalizes with paxillin at focal
adhesions and at the leading edge of migrating fibroblasts.
Moreover, ectopic expression of either an actopaxin con-
struct–containing mutation of the paxillin-binding subdo-
main (PBS) or the COOH-terminal half of actopaxin re-
sulted in substantial reduction in the spreading/adhesion
efficiency of HeLa cells on collagen. These data suggest an
important role for actopaxin and/or the actopaxin–paxillin
interaction either in the regulation of integrin’s association
with the extracellular matrix or in the initial organization of
the actin cytoskeleton during cell adhesion and spreading.
 
Materials and Methods
 
Reagents and Antibodies
 
Rat collagen type I and 
 
a
 
-actinin antibody were obtained from Sigma-
Aldrich. Paxillin (clone 349) and p130
 
Cas
 
 (clone 21) antibodies were ob-
tained from Transduction Laboratories, paxillin Y118 antibody from Bio-
source International, actin antibody (clone C4) from Roche, and Xpress
 
antibody from Invitrogen. GFP antibody was a generous gift of Dr. P. Sil-
ver (Dana-Farber Cancer Institute, Boston, MA).
 
Cell Culture and Transfection
 
Human intestinal smooth muscle (HISM) cells, rat embryo fibroblasts
(REF-52), NIH3T3, HeLa, and Cos-7 cells were maintained in DME (Me-
diatech) supplemented with 10% (vol/vol) FBS (Atlanta Biologicals), 1 mM
glutamine, and 50 U/ml penicillin/50 
 
m
 
g/ml streptomycin (Sigma-Aldrich)
in a humidified chamber with 5% CO
 
2
 
. CHO-K1 cells were cultured in
modified Ham’s F-12 (Mediatech) supplemented with 10% (vol/vol) FBS
and 1% penicillin/streptomycin at 37
 
8
 
C. Rat intestinal epithelial cells
(IEC-18) were maintained in DME supplemented with 5% (vol/vol) FBS,
4 mM 
 
L
 
-glutamine, 0.1 U/ml insulin, and 50 U/ml penicillin/50 
 
m
 
g/ml strep-
tomycin. Lipofectamine (GIBCO BRL)-mediated transfection of CHO-
K1, HeLa, and Cos-7 cells was as described elsewhere (Brown et al., 1996).
 
Microsequencing, Cloning, and Mutagenesis
of Actopaxin
 
Paxillin glutathione 
 
S
 
-transferase (GST)-LD1 binding proteins from
chicken smooth muscle tissue lysate were separated by SDS-PAGE and
transferred to PVDF membrane as described previously (Turner et al.,
1999). Protein bands, including a 42-kD band, were visualized by Ponceau
S staining and excised. Proteolytic digestion, HPLC fractionation, and in-
ternal peptide sequencing were performed by Dr. John Leszyk (Worcester
Foundation for Biomedical Research, Worcester, MA). Peptide sequenc-
ing revealed peptides with identical sequences with mouse and human
EST clones in GenBank. The equivalent ESTs were obtained from Ge-
nome Systems and sequenced on both strands (BioResource Center, Cor-
nell University, Ithaca, NY). Sequencing and alignment of the EST clones
revealed a 1.4-kb sequence that contained all the peptide sequences de-
rived from the microsequencing of the 42-kD band. The full coding se-
quences for actopaxin (amino acids [aa] 1–372, both mouse and human)
were isolated by reverse transcriptase (RT)-PCR from NIH3T3 and HISM
cells, using forward oligonucleotide primer 5
 
9
 
-CGTCTAGAATGGCCA-
CATCCCCAC-3
 
9
 
 and reverse oligonucleotide primer 5
 
9
 
-CGTCTAGAT-
CACTCCACATTCCGG-3
 
9
 
. A nucleotide tail coding for the XbaI restric-
tion site (underlined nucleotides) was engineered at the 5
 
9
 
 end of each
primer to facilitate in-frame cloning into the XbaI site of pEGFP-C1
(CLONTECH Laboratories, Inc.) or pcDNA3.1HisC (Invitrogen) vectors.
The NH
 
2
 
-terminal half (aa 1–222) and the COOH-terminal half of acto-
paxin (aa 223–372) were also cloned in-frame with the Xpress tag in the
EcoRI site of pcDNA3.1HisC vector. A double point mutant of the PBS
domain of actopaxin (val
 
282
 
gly/leu
 
285
 
arg) was generated using the Quick
Change Mutagenesis kit (Stratagene) according to the instructions of the
manufacturer. All actopaxin constructs were sequenced on both strands
(BioResource Center, Cornell University, Ithaca, NY). The sequence data
for human and mouse actopaxin are available from GenBank/EMBL/
DDBJ under accession nos. AF264765 and AF264766, respectively.
 
Preparation of Fusion Proteins and Binding Assays
 
Individual GST fusion proteins of paxillin LD motifs, as well as GST wild-
type paxillin (aa 1–559), were expressed in 
 
Escherichia coli 
 
(DH5
 
a
 
) and
purified on glutathione–agarose beads as described previously (Turner et
al., 1999). GST-actopaxin fusion proteins were generated by subcloning
the full-length actopaxin (aa 1–372) into the EcoRI site of pGEX-1 vector
(Amersham Pharmacia Biotech), the NH
 
2
 
-terminal half (aa 1–222) into
the BamHI sites of pGEX-2T, and the COOH-terminal half (aa 223–372)
between the BamHI and EcoRI sites of pGEX-3X. Actopaxin fusion pro-
teins were expressed in BL21pLysS cells (Novagen).
For all
 
 
 
binding experiments, cells were lysed in lysis/binding buffer (10
mM Tris-HCl, pH 7.6, 50 mM NaCl, 1% NP-40, 10% glycerol) containing
protease inhibitors (Roche), followed by clarification for 15 min at 15,000 
 
g
 
.
Lysates (0.5–1 mg) were incubated for 4 h at 4
 
8
 
C with the GST-actopaxin or
GST-paxillin LD proteins (50 
 
m
 
g) bound to glutathione–Sepharose 4B
beads or with the appropriate antibodies coupled to protein A/G beads
(Santa Cruz Biotechnology, Inc.). After incubation, the beads were washed
three times with the same buffer, and bound proteins were separated by
12% SDS-PAGE and analyzed by Western blotting. In similar experiments,
GST-paxillin, GST-paxillin LD motifs, or GST-actopaxin fusion proteins
were incubated with either 
 
35
 
S-metabolically labeled actopaxin or actopaxin
PBS mutant generated by coupled in vitro transcription/translation (TNT;
Promega). Binding proteins were analyzed on SDS-PAGE gels followed by
enhanced fluorography using Amplify (Amersham Pharmacia Biotech). 
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Actin Cosedimentation Assays
 
Actin and 
 
a
 
-actinin were obtained from Cytoskeleton. GST-actopaxin fu-
sion proteins were prepared as described above and eluted from the glu-
tathione-agarose beads with GST elution buffer (20 mM glutathione, 50
mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% 
 
b
 
-mercaptoethanol). Before
performing actin binding studies, all samples were dialyzed for 16 h at 4
 
8
 
C
against 2,000 volumes of actin-binding buffer (10 mM Tris-HCl, pH 7.6,
 
100 mM KCl, 2 mM MgCl
 
2
 
, 1 mM CaCl
 
2
 
, 0.5 mM ATP, 0.5 mM DTT), fol-
lowed by centrifugation in a Beckman Coulter airfuge (150,000 
 
g
 
) for 1 h
at room temperature to eliminate protein aggregates. F-actin was pre-
pared by polymerization of G-actin in the presence of binding buffer for
1 h at room temperature. F-actin (23 
 
m
 
M) was incubated with GST-acto-
paxin fusion protein (1 
 
m
 
M), purified 
 
a
 
-actinin (2 
 
m
 
M), BSA (2 
 
m
 
M), or
GST (50 
 
m
 
M) for 30 min at room temperature. After incubation, the sam-
ples were centrifuged in a Beckman airfuge (150,000 
 
g
 
) for 1 h at room
Figure 1. Sequence analysis of acto-
paxin. (A) Schematic representation of
the domain structure of actopaxin
showing the relative positions of CH
domains (CH1 and CH2) and PBS se-
quence (PBS). (B) Nucleotide and de-
duced aa sequence of human actopaxin
cDNA. The gray boxes highlight the
CH domains. The aa sequences of the
three peptides derived from the mi-
crosequencing of the 42-kD band are
underlined. The PBS is highlighted in
yellow. The sequence data are avail-
able from GenBank/EMBL/DDBJ da-
tabases under accession no. AF264765.
(C) Sequence alignment of CH do-
mains from different actin-binding pro-
teins. The CH1 domains are aligned on
the top and the CH2 domains on the
bottom. Residues conserved in .90%
of the sequences are colored red; resi-
dues conserved in .50% of the se-
quences are colored blue. The names,
database accession numbers (SWISS-
PROT [SW] or SPTREMBL [SE]),
and sequence residues are as follows:
H_Actp, human actopaxin aa 96–202
and aa 262–368; H_Spc, human b spec-
trin, SW Q01082, aa 53–163 and aa
172–281; H-Aac, human a-actinin1 SW
P12814, aa 30–140 and aa 143–253;
H_Dtn_l, human dystonin isoform 1,
SE Q13266, aa 34–143 and aa 150–258;
H_Pct, human plectin, SE Q15149, aa
178–287 and aa 294–403; H_Dys, hu-
man dystrophin, SW P11532, aa 14–124
and aa 133–243; H_Fil, human non-
muscle filamin (ABP-280), SW P21333,
aa 42–154 and aa 165–272; Dd_ABP-
120,  D. discoideum ABP-120, SW
P13466, aa 11–122 and aa 124–230;
H_Fim, human fimbrin, SW P13797, aa
119–241 and aa 260–379. The figure
was produced with MULTALIN soft-
ware (Corpet, 1988). (D) Sequence
alignment of the PBS domains of acto-
paxin, vinculin, and FAK. Identical
residues are colored red; residues con-
served in at least two of the sequences
are colored blue. Asterisks indicate the
aa that have been reported previously
to be critical for FAK binding to paxil-
lin and which are mutated in the acto-
paxin PBS mutant. 
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temperature to pellet the actin filaments and associated proteins. The su-
pernatant and pellet fractions were analyzed by 10% SDS-PAGE and vi-
sualized with Coomassie blue.
 
RNA Isolation, PCR, RT-PCR, and Northern
Blot Analysis
 
Total RNA from HISM and NIH3T3 cells was prepared using the Trizol
reagent (GIBCO BRL) according to the manufacturer’s protocol. cDNAs
 
were prepared from total RNAs using SuperScriptII (GIBCO BRL). PCR
and RT-PCR were performed using the Expand High Fidelity PCR sys-
tem (Roche). A human tissue Northern blot containing 2 
 
m
 
g of poly(A)
 
1
 
RNA (CLONTECH Laboratories, Inc.) was probed with a 
 
32
 
P-labeled ac-
topaxin probe encompassing the actopaxin ORF and hybridized in Quick-
Hyb hybridization solution according to the manufacturer’s instructions
(CLONTECH Laboratories, Inc.).
 
Antibody Preparation
 
GST-actopaxin was purified on glutathione–Sepharose 4B (Amersham
Pharmacia Biotech), eluted from the beads, and dialyzed against phosphate-
buffered saline. Rabbits were immunized by repeated subcutaneous injec-
tions of the purified fusion protein (300 
 
m
 
g) suspended in Freund’s Adjuvant.
 
Immunofluorescence Microscopy
 
Indirect immunofluorescence analysis was performed as described previ-
ously (Brown et al., 1996). Photographs were taken on a ZEISS Axiophot
photomicroscope equipped with epifluorescence illumination using Tmax
400 film (Eastman Kodak Co.). Images were scanned using Coolscan II
(Eastman Kodak Co.) and processed using Adobe
 
 
 
Photoshop
 
®
 
 v3.0.5.
 
Fibroblast Wound-healing Assay
 
To stimulate the formation of lamellipodia, scrape-wound healing assays
were performed on HISM cells grown on coverslips. Confluent, serum-
starved monolayers of HISM cells were wounded by scraping away a
swath of cells with a P1000 pipet tip. The coverslips were rinsed twice with
phosphate-buffered saline to remove wound-derived cell aggregates, and
then incubated in complete media for 3 h at 37
 
8
 
C, 5% CO
 
2
 
. The coverslips
were subsequently fixed and processed for immunofluorescence micros-
copy as described previously (Brown et al., 1996).
 
Adhesion and Spreading Assays
 
HeLa cells, transiently transfected with Xpress-tagged actopaxin con-
structs or with an Xpress-tagged 
 
b
 
-galactosidase plasmid (Invitrogen),
were resuspended 18 h after transfection, washed once in complete me-
dium with the addition of 10 
 
m
 
g trypsin inhibitor (Sigma-Aldrich), and
then washed three times with serum-free medium. Thereafter, the cells
were resuspended in serum-free medium containing 1% BSA and rocked
for 1 h at 37
 
8
 
C. The cells were then plated on collagen type I (10 
 
m
 
g/ml)
for 45, 90, or 180 min in serum-free medium, or for 12 h in complete me-
dium. For each time point, slips were fixed in 3.7% formaldehyde and pro-
cessed for immunofluorescence with Xpress antibody. To monitor trans-
fection efficiency before the spreading assay, a coverslip (present in
transfection plates) was processed for immunofluorescence before
trypsinization. Adhesion and spreading efficiency was expressed as the
percentage of adherent transfected cells at each time in relation to the
number of adherent transfected cells after 12 h in complete medium (des-
ignated 100%). A minimum of 200 cells were analyzed per construct per
time point. The results represent the mean of three experiments 
 
6 
 
SD.
 
Results
 
Molecular Cloning of Actopaxin
 
Recently, we have described the identification and char-
acterization of several paxillin LD4 motif–binding pro-
teins (Turner et al., 1999). During the course of these
studies additional LD motif–binding proteins were de-
tected. Here, we describe the cloning and characteriza-
tion of one of these proteins, a 42-kD protein initially
identified through its association with the paxillin LD1
motif. Three peptide sequences obtained from microse-
quencing of the 42-kD LD1–binding protein (underlined,
Fig. 1 B) indicated 100% identity with hypothetical trans-
lation products of mouse ESTs (sequence data avail-
able from GenBank/EMBL/DDBJ under accession nos.
AA013795 and AA073392). These ESTs were obtained
and sequenced in their entirety and were found to have
overlapping sequence information. The predicted ORF
Figure 2. Expression of actopaxin protein in various tissues and
cell lines. Organs were dissected from a healthy adult rat, homog-
enized, and lysed in SDS-PAGE sample buffer. 50 mg of each ly-
sate was loaded per lane. (A) Coomassie blue staining of the gel.
(B) Western blotting of an identical gel shown in A probed with
the actopaxin antibody. (C) The same blot was stripped and re-
probed with an actin antibody to indicate relative loading among
lanes. (D) Western blot of total lysates (50 mg) from HISM cells,
rat embryo fibroblasts (REF-52), and rat intestinal epithelial cells
(IEC-18) probed with the actopaxin antibody. 
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of the combined EST sequences encodes a protein of 372
aa with an estimated molecular mass of 42.1 kD. Both the
human and mouse clones (sequence data available from
GenBank/EMBL/DDBJ under accession no. AF264765/6)
containing the entire ORF for this protein were cloned
by RT-PCR from HISM cells or mouse NIH3T3 fibro-
blast cells, respectively. We have named this 42-kD pro-
tein actopaxin in recognition of its actin- and paxillin-
binding properties as demonstrated below.
 
Protein Sequence and Structural Features of Actopaxin
 
Comparison of the deduced aa sequences of human
and mouse actopaxin indicates that this novel protein is
highly conserved between species, sharing 98.9% identity
at the aa level. Computer-assisted databank searches re-
vealed that actopaxin shares highest homology with two
recently reported sequences: AK001655, 98% identity; and
AL159142, 75% identity. In addition, actopaxin shares
relatively high homology (48% identity) with a 
 
Cae-
norhabditis elegans
 
 protein, which is related to 
 
a
 
-actinin
(AF016687), and 27% identity with most of the 
 
a
 
-actinin
family members. A closer examination of the domain
structure of actopaxin revealed the presence of two CH
domains in tandem array designated CH1 (aa 96–203) and
CH2 (aa 263–369) (Fig. 1, A and B). CH domains, espe-
cially when presented in tandem, have been shown to
function as F-actin–binding domains in several structural
proteins including 
 
a
 
-actinin, spectrin, and fimbrin (Banue-
los et al., 1998). An alignment of the CH domains of acto-
paxin with those of representative members of the CH
domain family demonstrate significant conservation of
consensus forming residues (Fig. 1 C).
Consistent with a model in which paxillin LD motifs
interact with their binding partners through conserved
sequences known as PBS (Wood et al., 1994; Tachibana
et al., 1995; Brown et al., 1998a; Turner et al., 1999), we
have identified a PBS within the CH2 domain of acto-
paxin (highlighted in green, Fig. 1, A and B). The acto-
paxin PBS (aa 273–290) displays 38.8% identity (55.5%
conservation) with the vinculin PBS (aa 951–989) and
27.7% identity (33.3% conservation) with the FAK
PBS. Sequence alignment of the actopaxin PBS se-
quence with the PBS sequences of vinculin and FAK re-
vealed conservation among all three proteins. Valine
 
928
 
and leucine
 
931
 
 of FAK have previously been shown to
be essential for binding to paxillin (Tachibana et al.,
1995) (Fig. 1 D). The corresponding aa of actopaxin,
valine
 
282
 
, and leucine
 
285
 
 were mutated to glycine and
arginine, respectively, and used in experiments de-
scribed in Figs. 8 and 9.
Structural predictions provided by the COILS algo-
rithm (Lupas et al., 1991) define actopaxin as a protein
with a theoretical pI of 5.49 and a predominantly coiled-
coil 
 
a
 
 helical structure, displaying an aa composition
with a high content of leucine (13.4%), glutamic acid
(8.9%), and lysine (8.6%). There is also a high proline
 
Figure 3.
 
Subcellular distribution of actopaxin. Immunofluores-
cence staining with actopaxin antibody of (A) rat embryo fibro-
blasts (REF-52), (C) HISM cells, and (E) rat intestinal epithelial
cells (IEC-18). Cells were stained simultaneously with rhodamine
phalloidin to visualize actin stress fibers (B), paxillin antibody to
demonstrate colocalization of actopaxin with paxillin at focal ad-
hesions (D), and 
 
b
 
-catenin antibody to demonstrate that acto-
paxin is absent from cell–cell contacts (F). Xpress-tagged acto-
paxin was transfected in CHO-K1 cells (G and H). The cells were
stained simultaneously with anti-Xpress antibody to detect the
transfected actopaxin (G) and rhodamine phalloidin (H) to visu-
alize actin stress fibers. Xpress-actopaxin was enriched at focal
adhesions at the ends of actin stress fibers (G and H). Actopaxin
is recruited to the focal complexes (arrows) at the leading edge of
migrating fibroblasts (I and J). HISM cells were stimulated to mi-
grate by scrape wounding a confluent monolayer of cells. 3 h after
wounding, the cells were stained for immunofluorescence micros-
copy with actopaxin antibody (I) and rhodamine phalloidin (J) to
visualize actin stress fibers. Bars: (A–H) 5 
 
m
 
m; (I and J) 2 
 
m
 
m. 
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E) where it colocalized with paxillin (Fig. 3, C and D).
Interestingly, although actopaxin also binds F-actin (see
below), no significant actopaxin was detected along the
length of the actin-rich stress fibers (i.e., outside the
confines of the focal adhesions). Similar to paxillin, ac-
topaxin did not localize to 
 
b
 
 catenin–containing cell–
cell adherens junctions of epithelial cells (IEC-18) (Fig.
3, E and F). A variable amount of perinuclear staining
for actopaxin was observed in all cell types examined.
To confirm the subcellular distribution of actopaxin, a
cDNA of actopaxin linked to the NH
 
2
 
-terminal Xpress
epitope of the pcDNA3HisC vector was transfected into
CHO-K1 cells. Xpress-tagged actopaxin localized to focal
adhesions at the ends of actin stress fibers (Fig. 3, G and
H). The same results were obtained with a GFP–actopaxin
construct (data not shown).
In addition to its localization to focal adhesions, paxillin
has been demonstrated to localize to the small integrin-
based adhesions called focal complexes found at the ventral
surface of newly formed lamellipodia (Nobes and Hall,
1995). To determine if actopaxin is present in these highly
dynamic structures, a wound-healing assay was performed
on confluent monolayers of HISM cells. Cells were scraped
from a region of the glass coverslip and the remaining cells
were allowed to migrate into the wound. Staining of the mi-
grating cells with the actopaxin antibody demonstrated that
as with paxillin, actopaxin is distributed in discrete focal
complexes at the extreme leading edge of the cells at the
base of the lamellipodia, as well as in more robust focal ad-
hesions within the body of the cells (Fig. 3, I and J). These
results potentially implicate actopaxin in the early events of
cytoskeletal reorganization that accompany cell migration.
 
Actopaxin Selectively Binds Paxillin LD1 and
LD4 Motifs
 
Our previous characterization of paxillin LD–binding pro-
teins has revealed that although some binding proteins are
Figure 4. Actopaxin binds to
the LD1 and LD4 motifs of
paxillin. (A) Coomassie blue
staining of the GST-paxillin
LD motif fusion proteins.
(B) Each paxillin LD motif
fusion protein was incubated
with 200 mg total lysate from
REF-52 cells. Coprecipitat-
ing proteins were resolved by
SDS-PAGE and transferred
to nitrocellulose. The mem-
brane was probed with acto-
paxin antibody (top). The
same blot was stripped and
probed with a-actinin anti-
body (bottom). (C) Individ-
ual GST-LD domains of pax-
illin were incubated with in
vitro–translated  35S-labeled
actopaxin and binding pro-
teins, precipitated using glu-
tathione-agarose beads, re-
solved by SDS-PAGE, and
visualized by fluorography.
 
content at its extreme NH
 
2
 
 terminus (aa 1–95). Motif
analysis of actopaxin indicates multiple potential phos-
phorylation sites for the cell cycle regulatory kinase
p34
 
cdc2
 
 in this NH
 
2
 
 terminus region (aa 1–95), a potential
tyrosine phosphorylation site (aa 117–124), and multiple
consensus sequences for protein kinase C and casein ki-
nase II phosphorylation.
 
Messenger RNA and Protein Expression of Actopaxin
 
The expression pattern of actopaxin mRNA in various hu-
man adult tissues was examined by Northern blot analysis
at high stringency using the human actopaxin ORF as a
probe. Although ubiquitous, actopaxin mRNA was prima-
rily expressed in the heart and pancreas. Several tran-
scripts ranging from 1.4 kb to 
 
z
 
8 kb were detected (data
not shown). The presence of these transcripts suggests that
actopaxin is a member of a larger family of proteins.
To examine the expression pattern of actopaxin pro-
tein, a polyclonal antiserum was produced against a
GST fusion protein of full-length actopaxin (aa 1–372).
Western blotting of total cell lysates prepared from sev-
eral rat tissues and cell lines indicated the presence of a
major protein migrating just above the 42-kD actin
band in all tissues examined (Fig. 2, A–C) and in all cell
lines tested (Fig. 2 D). The absence of actopaxin from
the skeletal muscle sample is most likely due to the ab-
sence in this particular preparation of myotendinous
junctions, a specialized region at the end of skeletal
muscle fibers enriched in focal adhesion proteins (Tid-
ball et al., 1986; Turner et al., 1991).
 
Actopaxin Subcellular Localization
 
To evaluate the subcellular distribution of actopaxin,
REF-52, HISM, and IEC-18 cells were processed for
immunofluorescence microscopy using the actopaxin
antibody. In all cell lines examined, actopaxin demon-
strated robust focal adhesion staining (Fig. 3, A, C, and 
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restricted to a single LD motif (e.g., p95PKL to LD4), oth-
ers bind to multiple LD motifs (vinculin to LD1, LD2, and
LD4 and FAK to LD2 and LD4) (Turner et al., 1999). To
determine if actopaxin binds exclusively to LD1, each pax-
illin LD motif was synthesized as a GST fusion protein
(Fig. 4 A) and incubated with smooth muscle cell lysates in
a precipitation binding experiment followed by Western
 
blotting with actopaxin antibody. Actopaxin bound prima-
rily to LD1 but also to LD4. Reprobing of the blot with
 
a
 
-actinin antibody revealed that 
 
a
 
-actinin was unable to
bind any paxillin LD motif (Fig. 4 B), thus confirming the
specificity of actopaxin–paxillin binding. Alternatively, the
same paxillin LD motif fusion proteins were incubated with
in vitro–translated 
 
35
 
S-labeled full-length actopaxin to dem-
onstrate direct binding to paxillin LD1 and LD4 (Fig. 4 C).
 
Actopaxin Binds Paxillin and Hic-5 In Vitro
 
To delineate the paxillin-binding site on actopaxin, GST
fusion proteins containing actopaxin wild-type (aa 1–372),
actopaxin NH
 
2
 
 terminus (aa 1–222), actopaxin COOH ter-
minus (aa 223–372), and GST alone (Fig. 5 A) were incu-
bated with REF-52 lysates and the precipitates were ana-
lyzed by Western blotting. The blots were probed with a
paxillin antibody that recognizes both paxillin and the re-
lated 50-kD protein hic-5 (Brown et al., 1996; Hagmann et
al., 1998). Both paxillin and hic-5 were detected in copre-
cipitates using full-length and COOH terminus actopaxin
fusion proteins (Fig. 5 B). This robust binding of paxillin
to the COOH terminus (aa 223–372) region of actopaxin is
consistent with the presence of a PBS domain within that
domain (see Fig. 1). To control for nonspecific binding, the
blots were reprobed with vinculin antibody. No signal in
any precipitation lane was obtained, thus excluding an ac-
topaxin–vinculin association. To confirm these results and
demonstrate a direct association between actopaxin and
paxillin, GST-actopaxin fusion proteins were incubated
with in vitro–translated 
 
35
 
S-labeled full-length paxillin.
Bound proteins were detected by SDS-PAGE followed by
fluorography. Binding to paxillin occurred only with full-
length actopaxin and the actopaxin COOH terminus fu-
sion protein (Fig. 5 C).
 
Actopaxin is an F-Actin–binding Protein
 
The presence of tandem CH domains in several actin-
binding proteins and the significant homology of acto-
paxin with spectrin and 
 
a
 
-actinins suggest that acto-
paxin may associate directly with F-actin. To test this
hypothesis, actin cosedimentation assays were performed
using a GST fusion protein of wild-type actopaxin. 
 
a
 
-Acti-
nin was used as a positive control for actin binding, and
GST and BSA controlled for nonspecific actin interac-
tions. In the absence of F-actin, the GST-actopaxin
fusion protein was found in the supernatant. In the
presence of actin, however, a significant portion of the
GST-actopaxin fusion protein was found to cosediment
with F-actin (Fig. 6).
 
In Vivo Association of Actopaxin with Paxillin 
and Actin
 
To demonstrate an
 
 
 
association in vivo between actopaxin,
paxillin, and actin, GFP-actopaxin was transfected into
Cos-7 cells. 48 h after transfection, total lysates from trans-
fectants were immunoprecipitated with GFP antibody or
with mouse IgG. Immunoprecipitates were separated by
SDS-PAGE and transferred to nitrocellulose, and the im-
munoblots were probed sequentially with paxillin/hic-5,
GFP, p130
 
Cas, and actin antibodies. Paxillin and hic-5, as
well as actin, coprecipitated with GFP-actopaxin but not
Figure 5. The second CH domain of actopaxin binds directly
to paxillin and hic-5 in vitro. (A) Coomassie blue–stained gel
of GST-actopaxin fusion proteins wild-type actopaxin (1–372),
NH2 terminus actopaxin (1–222), COOH terminus actopaxin
(223–372). (B) GST-actopaxin fusion proteins shown in A
were incubated with 300 mg of total lysate from REF-52 cells.
Coprecipitated proteins were resolved by SDS-PAGE and
transferred to nitrocellulose. The membrane was probed with
paxillin antibody (clone 349) that recognizes paxillin and hic-5
(top). The same blot was stripped and reprobed with vinculin
antibody (bottom). (C) Paxillin was 35S-metabolically labeled
in vitro by coupled transcription/translation and tested for its
ability to bind directly to GST-actopaxin fusion proteins.The Journal of Cell Biology, Volume 151, 2000 1442
the control IgG. In contrast, p130Cas was not detected in
the immunoprecipitates (Fig. 7 A).
To evaluate the interaction between endogenous acto-
paxin and paxillin, coimmunoprecipitation experiments
were performed using REF-52 or HISM cells. Total lysates
from both of these cell lines were incubated with acto-
paxin antibody or with control rabbit IgG. Immunoprecip-
itates were probed on Western blots with paxillin and
a-actinin antibodies. Paxillin was efficiently coimmuno-
precipitated with actopaxin antibody, whereas a-actinin
failed to bind (Fig. 7 B).
Abrogation of the Actopaxin–Paxillin Association 
Renders Actopaxin Incapable of Localizing to
Focal Adhesions
To investigate the importance of the actopaxin–paxillin as-
sociation in the localization of actopaxin to focal adhe-
sions, we generated a double point mutation within the
PBS domain of actopaxin (val282gly/leu285arg). These two
residues are conserved in the PBS domains of vinculin and
FAK PBS (see Fig. 1 D) and, in the case of FAK, are es-
sential for paxillin binding (Tachibana et al., 1995). To
evaluate the ability of the actopaxin PBS mutant to bind
paxillin, GST-paxillin fusion protein was incubated with in
vitro–transcribed/translated  35S-labeled actopaxin or the
35S-labeled actopaxin PBS mutant. Bound proteins were
detected by SDS-PAGE followed by fluorography. Bind-
ing of paxillin occurred only with wild-type full-length ac-
topaxin and not with the actopaxin PBS mutant (Fig. 8 A).
When the actopaxin PBS mutant was transfected into ei-
ther CHO-K1 or HeLa cells, it was unable to localize to focal
adhesions, instead exhibiting a diffuse perinuclear and cyto-
plasmic distribution (Fig. 8 B). These results clearly demon-
strate the importance of the actopaxin–paxillin association in
the efficient recruitment of actopaxin to focal adhesions.
Actopaxin Is Involved in Cell Adhesion and Spreading 
of HeLa Cells
Cell adhesion and spreading are primarily mediated by inte-
grin adhesion to the extracellular matrix and involve sub-
stantial reorganization of the actin cytoskeleton. The pres-
ence of actopaxin in focal adhesions and focal complexes,
and its ability to link paxillin to actin, prompted us to inves-
tigate whether actopaxin is involved in the process of cell
adhesion. For this purpose, Xpress-tagged wild-type (aa
1–372) actopaxin, the NH2 terminus (aa 1–222), the COOH
terminus (aa 223–372), the actopaxin PBS mutant, and
b-galactosidase were transfected into HeLa cells and used
in cell adhesion assays to collagen. The full-length (aa 1–372)
construct was efficiently localized to focal adhesions within
45 min of postplating (Fig. 9 A, a). In contrast, the NH2-ter-
minal half of actopaxin (aa 1–222) showed a diffuse pattern
of cytoplasmic localization at either 45 min or 12 h postplat-
ing (Fig. 9 A, b and j). Interestingly, the COOH-terminal
half of actopaxin that contains the functional PBS domain
(Figs. 5 and 8) localized weakly to focal adhesions after 12 h
postplating (Fig. 9 A, k), confirming the presence of focal
adhesion binding activity within this region of the protein.
The actopaxin PBS mutant also showed a diffuse cytoplas-
mic staining without any evidence of focal adhesion staining
at all time points postplating (Fig. 9 A, d and l). Visualiza-
tion of the actin cytoskeleton in the transfected cells with
rhodamine phalloidin indicated that overexpression of the
COOH-terminal half of actopaxin or the actopaxin PBS
mutant results in a partial reduction in actin filament con-
tent during the initial phases of cell spreading (Fig. 9 A, g
and h). No significant differences were observed in the actin
cytoskeleton with any of the transfectants 12 h postplating
(Fig. 9 A, m–p). In contrast, the localization of paxillin to fo-
cal adhesions was unaffected by ectopic expression of any
actopaxin construct (Fig. 10 and data not shown).
Figure 6. Actin-binding ac-
tivity of GST-actopaxin. The
ability of actopaxin to associ-
ate with F-actin in vitro was
examined by actin cosedi-
mentation assays using GST-
actopaxin fusion protein.
The following recombinant
proteins were incubated with
skeletal muscle F-actin:
GST-actopaxin (lanes 4–5),
GST (lanes 6–7), a-actinin
(lanes 8–9), and BSA
(lanes 10–11). GST-acto-
paxin (lanes 2–3) and F-actin
(lanes 12–13) were also in-
cubated in the absence of
F-actin and GST-actopaxin,
respectively. The superna-
tant (S) and pellet (P) frac-
tions were analyzed by SDS-
PAGE on 10% gel stained
with Coomassie blue. Molec-
ular weight markers (M) are
shown (lane 1).Nikolopoulos and Turner Actopaxin, a New Actin- and Paxillin-binding Protein 1443
Interestingly, overexpression of either the actopaxin
COOH terminus or the PBS mutant resulted in a substan-
tial reduction in cell adhesion and spreading efficiency at
45 min postplating compared with cells expressing wild-
type full-length actopaxin, NH2 terminus actopaxin, or
b-galactosidase (see Fig. 9 C). Transfectants of each of the
actopaxin constructs or b-galactosidase were also assayed
after 90 or 180 min postplating, and their adhesion effi-
ciencies were analogous to the results at the 45-min time
point (data not shown). Together, these data provide
quantitative evidence that actopaxin plays an important
role in the adhesion and spreading process.
Discussion
Previously, we identified five leucine-rich repeating se-
quences within the NH2 terminus of paxillin, termed LD
motifs (Brown et al., 1996, 1998a). Consistent with our
proposed role for paxillin as a molecular adapter protein
involved in integrin-mediated cytoskeletal organization
and intracellular signaling, we determined that individual
LD motifs could serve as independent and selective bind-
ing interfaces for other focal adhesion proteins including
vinculin and FAK, as well as a novel Arf GAP protein
p95PKL (Turner et al., 1999). In this study, we have identi-
fied and characterized a new paxillin LD1- and LD4-bind-
ing protein called p42 actopaxin. Actopaxin, which binds
to paxillin through its PBS domain and colocalizes with
paxillin to focal adhesions and focal complexes, was also
found to bind directly to F-actin, suggesting a role for this
protein in actin cytoskeleton and focal adhesion assembly/
signaling associated with cell adhesion to the extracellular
matrix. Indeed, overexpression of an actopaxin mutant de-
fective in paxillin binding retarded the ability of cells to
adhere and spread on the extracellular matrix.
Actopaxin is composed primarily of two CH domains.
The CH domain, a module of z110 aa named after the
muscle regulatory protein calponin (Castresana and Sa-
raste, 1995), is a common feature of actin-binding proteins
(Banuelos et al., 1998). In general, two CH domains (des-
ignated CH1 and CH2) arranged in tandem constitute a
functional actin-binding domain in several families of
structural proteins including spectrin, a-actinin, filamin,
fimbrin, and dystrophin (Stradal et al., 1998). These struc-
tural actin-binding proteins generally dimerize and thereby
cross-link actin filaments into bundles or actin meshworks.
Although actopaxin binds F-actin in in vitro cosedimenta-
tion assays, it is unclear at this time whether actopaxin un-
dergoes a similar dimerization.
Actopaxin also contains a functional paxillin-binding PBS
domain that contains several residues conserved within the
PBS domains of vinculin and/or FAK (Tachibana et al., 1995;
Brown et al., 1996). Comparison with the crystal structure
analysis of filamin and spectrin CH domains (Carugo et al.,
1997; Banuelos et al., 1998) suggests that the PBS domain of
actopaxin, which lies between the first and second a-helix of
the CH2 domain, is in a solvent-exposed hydrophilic loop
and is thereby accessible for protein binding. Interestingly,
this extended loop is present in only a limited number of CH
domain–containing proteins (Banuelos et al., 1998), indicat-
ing that, although it is not required for the actin binding func-
tion of CH domains per se, it may indeed function as an addi-
tional protein-binding site in those proteins in which it is
present. Furthermore, fimbrin, another actin-binding focal
adhesion protein comprised almost totally of CH domains
(four), has recently been shown to bind monomers of the in-
termediate filament protein vimentin via a region within its
first CH domain (Correia et al., 1999), suggesting that CH do-
mains likely serve as multiple protein-binding modules.
Finally, actopaxin contains multiple potential p34cdc2 ki-
nase phosphorylation sites within its NH2 terminus. Phos-
phorylation of this domain of actopaxin may result in
conformational changes within the protein, affecting its
binding to actin and/or paxillin and thereby contributing
to the disassembly of focal adhesions and stress fibers that
Figure 7. Actopaxin binds to paxillin and actin in vivo. (A) GFP-
actopaxin was transfected into Cos-7 cells. After lysis, proteins
were immunoprecipitated from 400 mg of total lysate with an an-
tibody to either GFP or IgG control. 20 mg of total lysate and the
immunoprecipitates (IP) were subjected to SDS-PAGE followed
by Western blotting with antibodies to paxillin, GFP, actin, and
p130Cas. (B) Coimmunoprecipitation of paxillin with endogenous
actopaxin. Asynchronously growing adherent HISM cells were
lysed in coimmunoprecipitation buffer. Actopaxin and IgG im-
munoprecipitations were performed from 500 mg lysates and sub-
jected to SDS-PAGE followed by Western blotting with antibod-
ies to paxillin and a-actinin. Paxillin was coimmunoprecipitated
with the actopaxin antibody in contrast to the control IgG. No
binding of a-actinin to either actopaxin or IgG coimmunoprecip-
itates was observed. IgG LC, immunoglobulin light chain.The Journal of Cell Biology, Volume 151, 2000 1444
occurs in adherent cells immediately before mitosis (Res-
nick et al., 1997; Kay et al., 2000).
The restricted localization of actopaxin to focal adhe-
sions, rather than along the length of the associated actin-
rich stress fibers, suggests that actopaxin may play an im-
portant role in linking these actin filaments to the plasma
membrane–associated protein complex. Furthermore, ac-
topaxin colocalizes with paxillin in the rudimentary focal
complexes formed at initial cell contact sites with the ex-
tracellular matrix formed during lamellipodial extension
at the leading edge of migrating cells (Nobes and Hall,
1995). The absence of well-organized actin filaments at fo-
cal complexes suggests that actopaxin, along with vinculin,
another paxillin- and actin-binding protein, may contrib-
ute directly to the initial nucleation of actin assembly at
these sites. Importantly, downregulation of proteins that
perform this function, such as vinculin, can lead to a trans-
formed phenotype (Rodriguez Fernandez et al., 1992),
suggesting that this class of proteins plays a critical role in
normal cell adhesion and growth control. Similarly, dis-
ruption of the actin cytoskeleton after infection of cells by
the papillomavirus may be the result of binding of the viral
oncoprotein E6 to paxillin LD motifs (Tong et al., 1997;
Vande Pol et al., 1998) thereby causing the functional dis-
placement of actopaxin and vinculin.
The identification of actopaxin extends the repertoire of
paxillin-associated proteins involved in the modulation of
the actin cytoskeleton. These paxillin LD motif–binding
proteins fall into two major classes. The first includes acto-
paxin and vinculin, proteins that interact directly with actin
and likely provide important structural links to the microfil-
ament system. The second comprises important regulatory
molecules associated with remodeling of the actin cytoskel-
eton by the Rho and Arf small GTPase families. For exam-
ple, a complex of proteins binding to paxillin LD4 contains
a putative activator of Rac/Cdc42, the nucleotide exchange
factor, PIX/COOL (Bagrodia et al., 1998; Manser et al.,
1998), and PAK, an effector of Rac and Cdc42 function as-
sociated with lamellipodia and filopodia extension (Ba-
grodia and Cerione, 1999; Daniels and Bokoch, 1999).
These proteins are linked to paxillin through novel an Arf
GAP protein, PKL (Turner et al., 1999), which is related to
the Git family (Premont et al., 2000), APP-1 (Di Cesare et
al., 2000), and PAG3 (Kondo et al., 2000). Although Arf
GTPases are considered to function primarily in vesicle
transport, they have recently been implicated in modifying
the actin cytoskeleton through direct stimulation of lamelli-
podia formation (Song et al., 1998), potentially through co-
ordinated activation of Rac (Di Cesare et al., 2000; Donald-
son and Jackson, 2000) or by regulating the translocation to
the plasma membrane of focal adhesion proteins such as
paxillin (Norman et al., 1998). Finally, FAK, which binds di-
rectly to paxillin through the LD2 and LD4 motifs (Turner
et al., 1999), associates with another regulator of p21 GTP-
ase function, the rho GAP, GRAF (Hildebrand et al.,
1996). Thus, paxillin is uniquely positioned to function as a
molecular scaffold at the plasma membrane. Its NH2 termi-
nus–containing LD motifs can potentially position these
regulatory and structural proteins in close proximity to each
other to facilitate the efficient conversion of environmental
signaling cues, transduced through integrin engagement
with the extracellular matrix, into the localized changes in
the actin cytoskeleton required for a variety of normal cel-
lular processes including cell motility and proliferation.
Our observations that certain actopaxin mutants—
namely the PBS mutant and the COOH terminus—inter-
fere with the ability of cells to adhere and spread on the ex-
tracellular matrix indicate a likely role for actopaxin in
these integrin-mediated events. We speculate that the ac-
topaxin PBS mutant interferes with the adhesion process
because it is unable to localize to the plasma membrane via
an association with paxillin. As a result, the mutant protein
Figure 8. Actopaxin-PBS mutant does not
bind paxillin in vitro and does not localize to
focal adhesions. (A) GST or GST-paxillin
was incubated with either in vitro–translated
35S-labeled Xpress-actopaxin or 35S-labeled
Xpress-actopaxin PBS mutant, and binding
proteins were resolved by SDS-PAGE and
visualized by fluorography. (B) Xpress-acto-
paxin PBS mutant was transfected into HeLa,
and the cells were stained simultaneously
with anti-Xpress antibody to detect the trans-
fected actopaxin and rhodamine phalloidin to
visualize actin stress fibers. There was no evi-
dence of focal adhesion localization for the
actopaxin PBS mutant, although some peri-
nuclear staining was detected. Bar, 5 mm.Nikolopoulos and Turner Actopaxin, a New Actin- and Paxillin-binding Protein 1445
likely sequesters in the cytosol other actopaxin-binding
proteins important to the adhesion process. In contrast, the
COOH terminus, which can bind paxillin but not actin
(Goldsmith et al., 1997; Banuelos et al., 1998; our unpub-
lished observations), may inhibit spreading by displacing
endogenous actopaxin from newly forming focal com-
plexes and/or adhesions, thereby preventing efficient orga-
nization of the actin cytoskeleton at these sites. This hy-
pothesis is supported by our observations indicating that,
although paxillin is efficiently localized to focal adhesions,
the actin cytoskeleton is less organized in cells expressing
the actopaxin COOH terminus or PBS mutants. However,
it should be noted that the overall organization of the actin
cytoskeleton in cells expressing these two mutants appears
normal several hours after plating. This likely reflects the
fact that there are several additional proteins such as talin
and vinculin that can function to link actin to the focal ad-
hesions (Burridge and Chrzanowska-Wodnicka, 1996) and
also may indicate that actopaxin functions primarily in cy-
toskeleton assembly only during the early phases of cell
spreading or during other dynamic events such as cell mi-
gration. Finally, our data do not preclude the possibility
Figure 9. Actopaxin medi-
ates adhesion and spreading
of HeLa cells. (A) HeLa cells
transfected with Xpress-acto-
paxin constructs were plated
on collagen type I–coated
slips for 45 min or for 12 h.
For each time point, slips
were fixed and processed for
immunofluorescence with
Xpress antibody. The wild-
type full-length actopaxin
(FL) localizes efficiently to
focal adhesions at both time
points (a and i). The COOH
terminus actopaxin (CT) lo-
calizes weakly to focal adhe-
sions at later time points (c
and k). Both the NH2 termi-
nus (NT) and the PBS mu-
tant (PBS MUT) failed to
target to focal adhesions (b–j
and d–l). Dual labeling of
actin in these cells with
rhodamine phalloidin indi-
cates that overexpression of
the CT or the PBS mutants
results in a partial reduction
in actin filament content dur-
ing the initial phases of cell
spreading (g and h). (B) Pro-
tein expression of the acto-
paxin constructs and b-galac-
tosidase control. 50 mg of
total cell lysates for each con-
struct of actopaxin transfec-
tants were run on SDS-PAGE,
transferred to nitrocellu-
lose, and probed with Xpress
antibody. (C) Adhesion and
spreading efficiency of HeLa
cells expressing wild-type
full-length, NH2 terminus,
COOH terminus, PBS mu-
tant actopaxin, or b-galactosi-
dase. Data represent the
mean  6  SD of three experi-
ments. Bar, 5 mm.The Journal of Cell Biology, Volume 151, 2000 1446
that actopaxin may influence integrin binding to the extra-
cellular matrix as previously demonstrated for the LIM do-
mains of paxillin (Brown et al., 1998b). Future experiments
will be directed towards examining these various potential
mechanisms of actopaxin action.
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